Items where Author is "Rizzo, M."

Article

(2026) Diagnostics in cardio-oncology: a focus on anthracyclines. Heart Failure Reviews. p. 20. ISSN 1382-4147

(2026) Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges. Frontiers in Oncology. p. 26. ISSN 2234-943X

(2026) Type 5 diabetes mellitus: redefining pancreatogenic diabetes through molecular, imaging, and AI-driven evidence. Frontiers in Endocrinology. p. 20. ISSN 1664-2392

(2025) Antibody-Drug Conjugates and Beyond: Next-Generation Targeted Therapies for Breast Cancer. Cancers. p. 38.

(2025) Doxorubicin and cyclophosphamide mode of chemotherapy-related cardiomyopathy: Review of preclinical model. Current problems in cardiology. p. 102882. ISSN 1535-6280 (Electronic) 0146-2806 (Linking)

(2025) Doxorubicin-induced cardiometabolic disturbances: what can we do? Frontiers in clinical diabetes and healthcare. p. 1537699. ISSN 2673-6616 (Electronic) 2673-6616 (Linking)

(2025) Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. International journal of cardiology. p. 132663. ISSN 1874-1754 (Electronic) 0167-5273 (Linking)

(2025) Type 5 diabetes mellitus: redefining pancreatogenic diabetes through molecular, imaging, and AI-driven evidence. Frontiers in Endocrinology. p. 1749805. ISSN 1664-2392 (Print) 1664-2392 (Electronic) 1664-2392 (Linking)